Ether (ETH) saw a notable price increase on November 4, trading at $2,427.91, which is a 5.74% rise over the past 24 hours. This price movement pushed ETH above the $2,400 level, signaling renewed interest or positive momentum in the digital asset market. The update was reported by Enna Lee from TokenPost, highlighting the ongoing activity in cryptocurrency trading. Investors may watch this trend for potential further gains or market shifts.
Ether price movement is the subject, with Pluang market data providing context. As of Nov 05, 2026 00:31 WIB, 45 of 50 major cryptocurrencies rose on Pluang. Ethereum (ETH) traded at Rp44.060.177 with a 5.70% gain, showing a typical hold time of 108 days and Pluang order activity at 69% Sell / 31% Buy. Algorand (ALGO) and Curve DAO Token (CRV) also showed strong gains of 6.29% and 6.21% respectively.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
